{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T13:30:36Z","timestamp":1788874236121,"version":"build-2803163510"},"reference-count":107,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T00:00:00Z","timestamp":1649721600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T00:00:00Z","timestamp":1649721600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004189","name":"Max-Planck-Gesellschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004189","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:title>Preface<\/jats:title><jats:p>Executive functions, learning, attention, and processing speed are imperative facets of cognitive performance, affected in neuropsychiatric disorders. In clinical studies on different patient groups, recombinant human (rh) erythropoietin (EPO) lastingly improved higher cognition and reduced brain matter loss. Correspondingly, rhEPO treatment of young rodents or EPO receptor (EPOR) overexpression in pyramidal neurons caused remarkable and enduring cognitive improvement, together with enhanced hippocampal long-term potentiation. The \u2018brain hardware upgrade\u2019, underlying these observations, includes an EPO induced ~20% increase in pyramidal neurons and oligodendrocytes in cornu ammonis hippocampi in the absence of elevated DNA synthesis. In parallel, EPO reduces microglia numbers and dampens their activity and metabolism as prerequisites for undisturbed EPO-driven differentiation of pre-existing local neuronal precursors. These processes depend on neuronal and microglial EPOR. This novel mechanism of powerful postnatal neurogenesis, outside the classical neurogenic niches, and on-demand delivery of new cells, paralleled by dendritic spine increase, let us hypothesize a physiological procognitive role of hypoxia-induced endogenous EPO in brain, which we imitate by rhEPO treatment. Here we delineate the <jats:italic>brain EPO circle<\/jats:italic> as working model explaining adaptive \u2018brain hardware upgrade\u2019 and improved performance. In this fundamental regulatory circle, neuronal networks, challenged by motor-cognitive tasks, drift into transient \u2018functional hypoxia\u2019, thereby triggering neuronal EPO\/EPOR expression.<\/jats:p>","DOI":"10.1038\/s41380-022-01551-5","type":"journal-article","created":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T16:46:01Z","timestamp":1649781961000},"page":"2372-2379","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Introducing the brain erythropoietin circle to explain adaptive brain hardware upgrade and improved performance"],"prefix":"10.1038","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8371-5711","authenticated-orcid":false,"given":"Hannelore","family":"Ehrenreich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Fernandez","family":"Garcia-Agudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes A.","family":"Steixner-Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justus B. H.","family":"Wilke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umer Javed","family":"Butt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,12]]},"reference":[{"key":"1551_CR1","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/0034-5687(86)90093-9","volume":"63","author":"W Jelkmann","year":"1986","unstructured":"Jelkmann W. Erythropoietin research, 80 years after the initial studies by Carnot and Deflandre. Respir Physiol. 1986;63:257\u201366.","journal-title":"Respir Physiol"},{"key":"1551_CR2","doi-asserted-by":"publisher","first-page":"36528","DOI":"10.1074\/jbc.X112.420356","volume":"287","author":"HF Lodish","year":"2012","unstructured":"Lodish HF. Translational control of protein synthesis: the early years. J Biol Chem. 2012;287:36528\u201335.","journal-title":"J Biol Chem"},{"key":"1551_CR3","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1101\/sqb.1995.060.01.012","volume":"60","author":"HF Lodish","year":"1995","unstructured":"Lodish HF, Hilton DJ, Klingm\u00fcller U, Watowich SS, Wu H. The erythropoietin receptor: biogenesis, dimerization, and intracellular signal transduction. Cold Spring Harb Symp Quant Biol. 1995;60:93\u2013104. https:\/\/doi.org\/10.1101\/sqb.1995.060.01.012.","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"1551_CR4","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1146\/annurev.me.29.020178.000411","volume":"29","author":"SE Graber","year":"1978","unstructured":"Graber SE, Krantz S. Erythropoietin and the control of red cell production. Annu Rev Med. 1978;29:51\u201366.","journal-title":"Annu Rev Med"},{"key":"1551_CR5","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1146\/annurev.ph.51.030189.004213","volume":"51","author":"C Bauer","year":"1989","unstructured":"Bauer C, Kurtz A. Oxygen sensing in the kidney and its relation to erythropoietin production. Annu Rev Physiol. 1989;51:845\u201356.","journal-title":"Annu Rev Physiol"},{"key":"1551_CR6","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/nrn1687","volume":"6","author":"M Brines","year":"2005","unstructured":"Brines M, Cerami A. Emerging biological roles for erythropoietin in the nervous system. Nat Rev Neurosci. 2005;6:484\u201394.","journal-title":"Nat Rev Neurosci"},{"key":"1551_CR7","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.nurt.2008.10.041","volume":"6","author":"A-L Sir\u00e9n","year":"2009","unstructured":"Sir\u00e9n A-L, Fa\u00dfhauer T, Bartels C, Ehrenreich H. Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system. Neurotherapeutics. 2009;6:108\u201327.","journal-title":"Neurotherapeutics"},{"key":"1551_CR8","first-page":"418","volume":"376","author":"P Ghezzi","year":"2010","unstructured":"Ghezzi P, Bernaudin M, Bianchi R, Blomgren K. Erythropoietin: not just about erythropoiesis (vol 375, pg 2142, 2010). Lancet. 2010;376:418\u2013418.","journal-title":"Lancet"},{"key":"1551_CR9","doi-asserted-by":"publisher","first-page":"10526","DOI":"10.1073\/pnas.97.19.10526","volume":"97","author":"ML Brines","year":"2000","unstructured":"Brines ML, Ghezzi P, Keenan S, Agnello D, De Lanerolle NC, Cerami C, et al. Erythropoietin crosses the blood\u2013brain barrier to protect against experimental brain injury. Proc Natl Acad Sci. 2000;97:10526\u201331.","journal-title":"Proc Natl Acad Sci"},{"key":"1551_CR10","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.bpa.2010.10.005","volume":"24","author":"D Sargin","year":"2010","unstructured":"Sargin D, Friedrichs H, El-Kordi A, Ehrenreich H. Erythropoietin as neuroprotective and neuroregenerative treatment strategy: comprehensive overview of 12 years of preclinical and clinical research. Best Pract Res Clin Anaesthesiol. 2010;24:573\u201394.","journal-title":"Best Pract Res Clin Anaesthesiol"},{"key":"1551_CR11","doi-asserted-by":"crossref","unstructured":"Newton SS, Sathyanesan M. Erythropoietin and non-erythropoietic derivatives in cognition. Front Pharmacol. 2021;12:728725.","DOI":"10.3389\/fphar.2021.728725"},{"key":"1551_CR12","doi-asserted-by":"crossref","unstructured":"Dey S, Lee J, Noguchi CT. Erythropoietin non-hematopoietic tissue response and regulation of metabolism during diet induced obesity. Front Pharmacol. 2021;12:725734.","DOI":"10.3389\/fphar.2021.725734"},{"key":"1551_CR13","doi-asserted-by":"publisher","first-page":"803","DOI":"10.2119\/molmed.2015.00192","volume":"21","author":"C Ott","year":"2015","unstructured":"Ott C, Martens H, Hassouna I, Oliveira B, Erck C, Zafeiriou M-P, et al. Widespread expression of erythropoietin receptor in brain and its induction by injury. Mol Med. 2015;21:803\u201315.","journal-title":"Mol Med"},{"key":"1551_CR14","doi-asserted-by":"publisher","first-page":"4635","DOI":"10.1073\/pnas.95.8.4635","volume":"95","author":"M Sakanaka","year":"1998","unstructured":"Sakanaka M, Wen T-C, Matsuda S, Masuda S, Morishita E, Nagao M, et al. In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc Natl Acad Sci. 1998;95:4635\u201340.","journal-title":"Proc Natl Acad Sci"},{"key":"1551_CR15","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1203\/00006450-199801000-00007","volume":"43","author":"SE Juul","year":"1998","unstructured":"Juul SE, Anderson DK, Li Y, Christensen RD. Erythropoietin and erythropoietin receptor in the developing human central nervous system. Pediatr Res. 1998;43:40\u201349.","journal-title":"Pediatr Res"},{"key":"1551_CR16","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1111\/j.1460-9568.1996.tb01252.x","volume":"8","author":"HH Marti","year":"1996","unstructured":"Marti HH, Wenger RH, Rivas LA, Straumann U, Oigicaylioglu M, Henn V, et al. Erythropoietin gene expression in human, monkey and murine brain. Eur J Neurosci. 1996;8:666\u201376.","journal-title":"Eur J Neurosci"},{"key":"1551_CR17","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.cellsig.2006.08.014","volume":"19","author":"M Um","year":"2007","unstructured":"Um M, Gross AW, Lodish HF. A \u201cclassical\u201d homodimeric erythropoietin receptor is essential for the antiapoptotic effects of erythropoietin on differentiated neuroblastoma SH-SY5Y and pheochromocytoma PC-12 cells. Cell Signal. 2007;19:634\u201345.","journal-title":"Cell Signal"},{"key":"1551_CR18","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1093\/brain\/awm203","volume":"130","author":"H Ehrenreich","year":"2007","unstructured":"Ehrenreich H, Fischer B, Norra C, Schellenberger F, Stender N, Stiefel M, et al. Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis. Brain. 2007;130:2577\u201388.","journal-title":"Brain"},{"key":"1551_CR19","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/BF03402029","volume":"8","author":"H Ehrenreich","year":"2002","unstructured":"Ehrenreich H, Hasselblatt M, Dembowski C, Cepek L, Lewczuk P, Stiefel M, et al. Erythropoietin therapy for acute stroke is both safe and beneficial. Mol Med. 2002;8:495\u2013505.","journal-title":"Mol Med"},{"key":"1551_CR20","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/sj.mp.4001907","volume":"12","author":"H Ehrenreich","year":"2007","unstructured":"Ehrenreich H, Hinze-Selch D, Stawicki S, Aust C, Knolle-Veentjer S, Wilms S, et al. Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin. Mol Psychiatry. 2007;12:206\u201320.","journal-title":"Mol Psychiatry"},{"key":"1551_CR21","doi-asserted-by":"publisher","first-page":"e647","DOI":"10.1161\/STROKEAHA.109.564872","volume":"40","author":"H Ehrenreich","year":"2009","unstructured":"Ehrenreich H, Weissenborn K, Prange H, Schneider D, Weimar C, Wartenberg K, et al. Recombinant human erythropoietin in the treatment of acute ischemic stroke. Stroke. 2009;40:e647\u2013e656.","journal-title":"Stroke"},{"key":"1551_CR22","doi-asserted-by":"publisher","first-page":"0","DOI":"10.4088\/JCP.13m08839","volume":"75","author":"KW Miskowiak","year":"2014","unstructured":"Miskowiak KW, Ehrenreich H, Christensen EM, Kessing LV, Vinberg M. Recombinant human erythropoietin to target cognitive dysfunction in bipolar disorder: a double-blind, randomized, placebo-controlled phase 2 trial. J Clin psychiatry. 2014;75:0\u20130.","journal-title":"J Clin psychiatry"},{"key":"1551_CR23","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1038\/npp.2013.335","volume":"39","author":"KW Miskowiak","year":"2014","unstructured":"Miskowiak KW, Vinberg M, Christensen EM, Bukh JD, Harmer CJ, Ehrenreich H, et al. Recombinant human erythropoietin for treating treatment-resistant depression: a double-blind, randomized, placebo-controlled phase 2 trial. Neuropsychopharmacology. 2014;39:1399\u2013408.","journal-title":"Neuropsychopharmacology"},{"key":"1551_CR24","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.biopsych.2014.12.013","volume":"78","author":"KW Miskowiak","year":"2015","unstructured":"Miskowiak KW, Vinberg M, Macoveanu J, Ehrenreich H, K\u00f8ster N, Inkster B, et al. Effects of erythropoietin on hippocampal volume and memory in mood disorders. Biol Psychiatry. 2015;78:270\u20137.","journal-title":"Biol Psychiatry"},{"key":"1551_CR25","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1093\/brain\/awh703","volume":"129","author":"A-L Sir\u00e9n","year":"2006","unstructured":"Sir\u00e9n A-L, Radyushkin K, Boretius S, K\u00e4mmer D, Riechers C-C, Natt O, et al. Global brain atrophy after unilateral parietal lesion and its prevention by erythropoietin. Brain. 2006;129:480\u20139.","journal-title":"Brain"},{"key":"1551_CR26","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/mp.2010.51","volume":"16","author":"T W\u00fcstenberg","year":"2011","unstructured":"W\u00fcstenberg T, Begemann M, Bartels C, Gefeller O, Stawicki S, Hinze-Selch D, et al. Recombinant human erythropoietin delays loss of gray matter in chronic schizophrenia. Mol Psychiatry. 2011;16:26\u201336.","journal-title":"Mol Psychiatry"},{"key":"1551_CR27","doi-asserted-by":"publisher","first-page":"2788","DOI":"10.1523\/JNEUROSCI.5013-06.2007","volume":"27","author":"K Miskowiak","year":"2007","unstructured":"Miskowiak K, O\u2019Sullivan U, Harmer CJ. Erythropoietin enhances hippocampal response during memory retrieval in humans. J Neurosci. 2007;27:2788\u201392.","journal-title":"J Neurosci"},{"key":"1551_CR28","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.clinph.2004.12.009","volume":"116","author":"RB Weiskopf","year":"2005","unstructured":"Weiskopf RB, Toy P, Hopf HW, Feiner J, Finlay HE, Takahashi M, et al. Acute isovolemic anemia impairs central processing as determined by P300 latency. Clin Neurophysiol. 2005;116:1028\u201332.","journal-title":"Clin Neurophysiol"},{"key":"1551_CR29","doi-asserted-by":"publisher","first-page":"3884","DOI":"10.1096\/fj.11-191197","volume":"26","author":"B Schuler","year":"2012","unstructured":"Schuler B, Vogel J, Grenacher B, Jacobs RA, Arras M, Gassmann M. Acute and chronic elevation of erythropoietin in the brain improves exercise performance in mice without inducing erythropoiesis. FASEB J. 2012;26:3884\u201390.","journal-title":"FASEB J"},{"key":"1551_CR30","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1080\/02640410500131340","volume":"24","author":"G Ninot","year":"2006","unstructured":"Ninot G, Connes P, Caillaud C. Effects of recombinant human erythropoietin injections on physical self in endurance athletes. J Sports Sci. 2006;24:383\u201391.","journal-title":"J Sports Sci"},{"key":"1551_CR31","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/sj.mp.4001442","volume":"9","author":"H Ehrenreich","year":"2004","unstructured":"Ehrenreich H, Degner D, Meller J, Brines M, Behe M, Hasselblatt M, et al. Erythropoietin: a candidate compound for neuroprotection in schizophrenia. Mol Psychiatry. 2004;9:42\u201354.","journal-title":"Mol Psychiatry"},{"key":"1551_CR32","doi-asserted-by":"publisher","first-page":"2000455","DOI":"10.1002\/biot.202000455","volume":"16","author":"M B\u00fcrgi","year":"2021","unstructured":"B\u00fcrgi M, Aparicio GI, Dorella A, Kratje R, Scorticati C, Oggero M. Novel erythropoietin\u2010based therapeutic candidates with extra N\u2010glycan sites that block hematopoiesis but preserve neuroplasticity. Biotechnol J. 2021;16:2000455.","journal-title":"Biotechnol J"},{"key":"1551_CR33","doi-asserted-by":"publisher","first-page":"10925","DOI":"10.1073\/pnas.0805594105","volume":"105","author":"M Brines","year":"2008","unstructured":"Brines M, Patel NS, Villa P, Brines C, Mennini T, De Paola M, et al. Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin. Proc Natl Acad Sci. 2008;105:10925\u201330.","journal-title":"Proc Natl Acad Sci"},{"key":"1551_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-03167-0","volume":"7","author":"C Bonnas","year":"2017","unstructured":"Bonnas C, W\u00fcstefeld L, Winkler D, Kronstein-Wiedemann R, Dere E, Specht K, et al. EV-3, an endogenous human erythropoietin isoform with distinct functional relevance. Sci Rep. 2017;7:1\u201315.","journal-title":"Sci Rep"},{"key":"1551_CR35","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1093\/brain\/awq101","volume":"133","author":"S Pankratova","year":"2010","unstructured":"Pankratova S, Kiryushko D, Sonn K, Soroka V, K\u00f8hler LB, Rathje M, et al. Neuroprotective properties of a novel, non-haematopoietic agonist of the erythropoietin receptor. Brain. 2010;133:2281\u201394.","journal-title":"Brain"},{"key":"1551_CR36","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1126\/science.1100891","volume":"305","author":"H Ehrenreich","year":"2004","unstructured":"Ehrenreich H. A boost for translational neuroscience. Science. 2004;305:184\u20135.","journal-title":"Science"},{"key":"1551_CR37","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1126\/science.1098313","volume":"305","author":"M Leist","year":"2004","unstructured":"Leist M, Ghezzi P, Grasso G, Bianchi R, Villa P, Fratelli M, et al. Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science. 2004;305:239\u201342.","journal-title":"Science"},{"key":"1551_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1741-7007-9-27","volume":"9","author":"D Sargin","year":"2011","unstructured":"Sargin D, El-Kordi A, Agarwal A, M\u00fcller M, Wojcik SM, Hassouna I, et al. Expression of constitutively active erythropoietin receptor in pyramidal neurons of cortex and hippocampus boosts higher cognitive functions in mice. BMC Biol. 2011;9:1\u201316.","journal-title":"BMC Biol"},{"key":"1551_CR39","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1111\/jnc.13445","volume":"136","author":"L W\u00fcstefeld","year":"2016","unstructured":"W\u00fcstefeld L, Winkler D, Janc OA, Hassouna I, Ronnenberg A, Ostmeier K, et al. Selective expression of a constitutively active erythropoietin receptor in GABA ergic neurons alters hippocampal network properties without affecting cognition. J Neurochem. 2016;136:698\u2013705.","journal-title":"J Neurochem"},{"key":"1551_CR40","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/0166-4328(83)90138-9","volume":"9","author":"M Carli","year":"1983","unstructured":"Carli M, Robbins T, Evenden J, Everitt B. Effects of lesions to ascending noradrenergic neurones on performance of a 5-choice serial reaction task in rats; implications for theories of dorsal noradrenergic bundle function based on selective attention and arousal. Behav Brain Res. 1983;9:361\u201380.","journal-title":"Behav Brain Res"},{"key":"1551_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/0471142301.ns0805hs31","volume":"31","author":"T Humby","year":"2005","unstructured":"Humby T, Wilkinson L, Dawson G. Assaying aspects of attention and impulse control in mice using the 5\u2010choice serial reaction time task. Curr Protoc Neurosci. 2005;31:1\u201315.","journal-title":"Curr Protoc Neurosci"},{"key":"1551_CR42","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.bbr.2006.03.029","volume":"171","author":"A Izquierdo","year":"2006","unstructured":"Izquierdo A, Wiedholz LM, Millstein RA, Yang RJ, Bussey TJ, Saksida LM, et al. Genetic and dopaminergic modulation of reversal learning in a touchscreen-based operant procedure for mice. Behav Brain Res. 2006;171:181\u20138.","journal-title":"Behav Brain Res"},{"key":"1551_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1741-7007-6-37","volume":"6","author":"B Adamcio","year":"2008","unstructured":"Adamcio B, Sargin D, Stradomska A, Medrihan L, Gertler C, Theis F, et al. Erythropoietin enhances hippocampal long-term potentiation and memory. BMC Biol. 2008;6:1\u201316.","journal-title":"BMC Biol"},{"key":"1551_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1741-7007-7-37","volume":"7","author":"A El-Kordi","year":"2009","unstructured":"El-Kordi A, Radyushkin K, Ehrenreich H. Erythropoietin improves operant conditioning and stability of cognitive performance in mice. BMC Biol. 2009;7:1\u20138.","journal-title":"BMC Biol"},{"key":"1551_CR45","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1038\/mp.2015.212","volume":"21","author":"I Hassouna","year":"2016","unstructured":"Hassouna I, Ott C, W\u00fcstefeld L, Offen N, Neher RA, Mitkovski M, et al. Revisiting adult neurogenesis and the role of erythropoietin for neuronal and oligodendroglial differentiation in the hippocampus. Mol Psychiatry. 2016;21:1752\u201367.","journal-title":"Mol Psychiatry"},{"key":"1551_CR46","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.bbr.2009.11.010","volume":"208","author":"B Adamcio","year":"2010","unstructured":"Adamcio B, Sperling S, Hagemeyer N, Walkinshaw G, Ehrenreich H. Hypoxia inducible factor stabilization leads to lasting improvement of hippocampal memory in healthy mice. Behav Brain Res. 2010;208:80\u201384.","journal-title":"Behav Brain Res"},{"key":"1551_CR47","first-page":"609","volume":"378","author":"RH Wenger","year":"1997","unstructured":"Wenger RH, Gassmann M. Oxygen (es) and the hypoxia-inducible factor-1. Biol Chem. 1997;378:609\u201316.","journal-title":"Biol Chem"},{"key":"1551_CR48","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/ng1395","volume":"36","author":"L Cao","year":"2004","unstructured":"Cao L, Jiao X, Zuzga DS, Liu Y, Fong DM, Young D, et al. VEGF links hippocampal activity with neurogenesis, learning and memory. Nat Genet. 2004;36:827\u201335.","journal-title":"Nat Genet"},{"key":"1551_CR49","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.neuropharm.2010.09.025","volume":"60","author":"C Leconte","year":"2011","unstructured":"Leconte C, Bihel E, Lepelletier F-X, Bou\u00ebt V, Saulnier R, Petit E, et al. Comparison of the effects of erythropoietin and its carbamylated derivative on behaviour and hippocampal neurogenesis in mice. Neuropharmacology. 2011;60:354\u201364.","journal-title":"Neuropharmacology"},{"key":"1551_CR50","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1111\/j.1471-4159.2007.04684.x","volume":"102","author":"MI Ransome","year":"2007","unstructured":"Ransome MI, Turnley AM. Systemically delivered Erythropoietin transiently enhances adult hippocampal neurogenesis. J Neurochem. 2007;102:1953\u201365.","journal-title":"J Neurochem"},{"key":"1551_CR51","doi-asserted-by":"publisher","first-page":"9733","DOI":"10.1523\/JNEUROSCI.21-24-09733.2001","volume":"21","author":"T Shingo","year":"2001","unstructured":"Shingo T, Sorokan ST, Shimazaki T, Weiss S. Erythropoietin regulates the in vitro and in vivo production of neuronal progenitors by mammalian forebrain neural stem cells. J Neurosci. 2001;21:9733\u201343.","journal-title":"J Neurosci"},{"key":"1551_CR52","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1523\/JNEUROSCI.4480-05.2006","volume":"26","author":"PT Tsai","year":"2006","unstructured":"Tsai PT, Ohab JJ, Kertesz N, Groszer M, Matter C, Gao J, et al. A critical role of erythropoietin receptor in neurogenesis and post-stroke recovery. J Neurosci. 2006;26:1269\u201374.","journal-title":"J Neurosci"},{"key":"1551_CR53","first-page":"6258","volume":"118","author":"SM Hattangadi","year":"2011","unstructured":"Hattangadi SM, Wong P, Zhang L, Flygare J, Lodish HF. From stem cell to red cell: regulation of erythropoiesis at multiple levels by multiple proteins, RNAs, and chromatin modifications. Blood J Am Soc Hematol. 2011;118:6258\u201368.","journal-title":"Blood J Am Soc Hematol"},{"key":"1551_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-15041-1","volume":"11","author":"D Wakhloo","year":"2020","unstructured":"Wakhloo D, Scharkowski F, Curto Y, Butt UJ, Bansal V, Steixner-Kumar AA, et al. Functional hypoxia drives neuroplasticity and neurogenesis via brain erythropoietin. Nat Commun. 2020;11:1\u201312.","journal-title":"Nat Commun"},{"key":"1551_CR55","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41577-019-0259-8","volume":"20","author":"LB Ivashkiv","year":"2020","unstructured":"Ivashkiv LB. The hypoxia\u2013lactate axis tempers inflammation. Nat Rev Immunol. 2020;20:85\u201386.","journal-title":"Nat Rev Immunol"},{"key":"1551_CR56","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.neuron.2020.02.025","volume":"106","author":"JA Kullmann","year":"2020","unstructured":"Kullmann JA, Trivedi N, Howell D, Laumonnerie C, Nguyen V, Banerjee SS, et al. Oxygen tension and the VHL-Hif1\u03b1 pathway determine onset of neuronal polarization and cerebellar germinal zone exit. Neuron. 2020;106:607\u201323. e605.","journal-title":"Neuron"},{"key":"1551_CR57","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.molcel.2008.04.009","volume":"30","author":"WG Kaelin Jr","year":"2008","unstructured":"Kaelin WG Jr, Ratcliffe PJ. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol Cell. 2008;30:393\u2013402.","journal-title":"Mol Cell"},{"key":"1551_CR58","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1113\/jphysiol.2013.251470","volume":"591","author":"PJ Ratcliffe","year":"2013","unstructured":"Ratcliffe PJ. Oxygen sensing and hypoxia signalling pathways in animals: the implications of physiology for cancer. J Physiol. 2013;591:2027\u201342.","journal-title":"J Physiol"},{"key":"1551_CR59","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/nrc1187","volume":"3","author":"GL Semenza","year":"2003","unstructured":"Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer. 2003;3:721\u201332.","journal-title":"Nat Rev Cancer"},{"key":"1551_CR60","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1111\/cns.13642","volume":"27","author":"J Liu","year":"2021","unstructured":"Liu J, Gu Y, Guo M, Ji X. Neuroprotective effects and mechanisms of ischemic\/hypoxic preconditioning on neurological diseases. CNS Neurosci Ther. 2021;27:869\u201382.","journal-title":"CNS Neurosci Ther"},{"key":"1551_CR61","doi-asserted-by":"crossref","unstructured":"Marmarelis VZ, Shin DC, Zhang R. The dynamic relationship between cortical oxygenation and endtidal CO2 transient changes is impaired in MCI patients. Front Physiol. 2021;12:772456.","DOI":"10.3389\/fphys.2021.772456"},{"key":"1551_CR62","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.cell.2020.03.029","volume":"181","author":"IH Jain","year":"2020","unstructured":"Jain IH, Calvo SE, Markhard AL, Skinner OS, To T-L, Ast T, et al. Genetic screen for cell fitness in high or low oxygen highlights mitochondrial and lipid metabolism. Cell. 2020;181:716\u201327. e711.","journal-title":"Cell"},{"key":"1551_CR63","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41580-020-0227-y","volume":"21","author":"P Lee","year":"2020","unstructured":"Lee P, Chandel NS, Simon MC. Cellular adaptation to hypoxia through hypoxia inducible factors and beyond. Nat Rev Mol cell Biol. 2020;21:268\u201383.","journal-title":"Nat Rev Mol cell Biol"},{"key":"1551_CR64","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.cell.2014.04.052","volume":"158","author":"TJ Yuen","year":"2014","unstructured":"Yuen TJ, Silbereis JC, Griveau A, Chang SM, Daneman R, Fancy SP, et al. Oligodendrocyte-encoded HIF function couples postnatal myelination and white matter angiogenesis. Cell. 2014;158:383\u201396.","journal-title":"Cell"},{"key":"1551_CR65","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1152\/physrev.1992.72.2.449","volume":"72","author":"W Jelkmann","year":"1992","unstructured":"Jelkmann W. Erythropoietin: structure, control of production, and function. Physiol Rev. 1992;72:449\u201389.","journal-title":"Physiol Rev"},{"key":"1551_CR66","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1042\/BJ20081055","volume":"414","author":"NS Kenneth","year":"2008","unstructured":"Kenneth NS, Rocha S. Regulation of gene expression by hypoxia. Biochem J. 2008;414:19\u201329.","journal-title":"Biochem J"},{"key":"1551_CR67","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.1242\/jeb.01049","volume":"207","author":"HH Marti","year":"2004","unstructured":"Marti HH. Erythropoietin and the hypoxic brain. J Exp Biol. 2004;207:3233\u201342.","journal-title":"J Exp Biol"},{"key":"1551_CR68","doi-asserted-by":"crossref","unstructured":"Suresh S, Rajvanshi PK, Noguchi CT. The many facets of erythropoietin physiologic and metabolic response. Front Physiol. 2020;10:1534.","DOI":"10.3389\/fphys.2019.01534"},{"key":"1551_CR69","doi-asserted-by":"publisher","first-page":"3485","DOI":"10.1097\/00001756-200011090-00017","volume":"11","author":"P Lewczuk","year":"2000","unstructured":"Lewczuk P, Hasselblatt M, Kamrowski-Kruck H, Heyer A, Unzicker C, Sir\u00e9n A-L, et al. Survival of hippocampal neurons in culture upon hypoxia: effect of erythropoietin. Neuroreport. 2000;11:3485\u20138.","journal-title":"Neuroreport"},{"key":"1551_CR70","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.tics.2007.06.009","volume":"11","author":"AF Kramer","year":"2007","unstructured":"Kramer AF, Erickson KI. Capitalizing on cortical plasticity: influence of physical activity on cognition and brain function. Trends Cogn Sci. 2007;11:342\u20138.","journal-title":"Trends Cogn Sci"},{"key":"1551_CR71","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cobeha.2015.01.005","volume":"4","author":"KI Erickson","year":"2015","unstructured":"Erickson KI, Hillman CH, Kramer AF. Physical activity, brain, and cognition. Curr Opin Behav Sci. 2015;4:27\u201332.","journal-title":"Curr Opin Behav Sci"},{"key":"1551_CR72","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1001\/archgenpsychiatry.2009.193","volume":"67","author":"F-G Pajonk","year":"2010","unstructured":"Pajonk F-G, Wobrock T, Gruber O, Scherk H, Berner D, Kaizl I, et al. Hippocampal plasticity in response to exercise in schizophrenia. Arch Gen Psychiatry. 2010;67:133\u201343.","journal-title":"Arch Gen Psychiatry"},{"key":"1551_CR73","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/s41586-021-03369-7","volume":"592","author":"NP Achilly","year":"2021","unstructured":"Achilly NP, Wang W, Zoghbi HY. Presymptomatic training mitigates functional deficits in a mouse model of Rett syndrome. Nature. 2021;592:596\u2013600.","journal-title":"Nature"},{"key":"1551_CR74","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ijdevneu.2019.08.003","volume":"78","author":"M Agarwal","year":"2019","unstructured":"Agarwal M, Johnston MV, Stafstrom CE. SYNGAP1 mutations: Clinical, genetic, and pathophysiological features. Int J Dev Neurosci. 2019;78:65\u201376.","journal-title":"Int J Dev Neurosci"},{"key":"1551_CR75","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1523\/JNEUROSCI.0420-19.2020","volume":"40","author":"TR Gamache","year":"2020","unstructured":"Gamache TR, Araki Y, Huganir RL. Twenty years of SynGAP research: from synapses to cognition. J Neurosci. 2020;40:1596\u2013605.","journal-title":"J Neurosci"},{"key":"1551_CR76","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/ejhg.2008.61","volume":"16","author":"KB Garber","year":"2008","unstructured":"Garber KB, Visootsak J, Warren ST. Fragile X syndrome. Eur J Hum Genet. 2008;16:666\u201372.","journal-title":"Eur J Hum Genet"},{"key":"1551_CR77","doi-asserted-by":"crossref","unstructured":"Butt UJ, Steixner-Kumar AA, Depp C, Sun T, Hassouna I, W\u00fcstefeld L, et al. Hippocampal neurons respond to brain activity with functional hypoxia. Mol Psychiatry 2021:1\u201318.","DOI":"10.1038\/s41380-020-00988-w"},{"key":"1551_CR78","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nature14582","volume":"523","author":"W Kimura","year":"2015","unstructured":"Kimura W, Xiao F, Canseco DC, Muralidhar S, Thet S, Zhang HM, et al. Hypoxia fate mapping identifies cycling cardiomyocytes in the adult heart. Nature. 2015;523:226\u201330.","journal-title":"Nature"},{"key":"1551_CR79","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/nmeth.4402","volume":"14","author":"X Qiu","year":"2017","unstructured":"Qiu X, Mao Q, Tang Y, Wang L, Chawla R, Pliner HA, et al. Reversed graph embedding resolves complex single-cell trajectories. Nat methods. 2017;14:979\u201382.","journal-title":"Nat methods"},{"key":"1551_CR80","doi-asserted-by":"publisher","first-page":"3164","DOI":"10.3390\/ijms22063164","volume":"22","author":"UJ Butt","year":"2021","unstructured":"Butt UJ, Hassouna I, Fernandez Garcia-Agudo L, Steixner-Kumar AA, Depp C, Barnkothe N, et al. CaMKII\u03b1 Expressing Neurons to Report Activity-Related Endogenous Hypoxia upon Motor-Cognitive Challenge. Int J Mol Sci. 2021;22:3164.","journal-title":"Int J Mol Sci"},{"key":"1551_CR81","first-page":"20935","volume":"13","author":"R Shapira","year":"2021","unstructured":"Shapira R, Gdalyahu A, Gottfried I, Sasson E, Hadanny A, Efrati S, et al. Hyperbaric oxygen therapy alleviates vascular dysfunction and amyloid burden in an Alzheimer\u2019s disease mouse model and in elderly patients. Aging (Albany N. Y). 2021;13:20935.","journal-title":"Aging (Albany N. Y)"},{"key":"1551_CR82","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.trci.2017.01.002","volume":"3","author":"U Bayer","year":"2017","unstructured":"Bayer U, Likar R, Pinter G, Stettner H, Demschar S, Trummer B, et al. Intermittent hypoxic\u2013hyperoxic training on cognitive performance in geriatric patients. Alzheimer\u2019s Dement Transl Res Clin Interventions. 2017;3:114\u201322.","journal-title":"Alzheimer\u2019s Dement Transl Res Clin Interventions"},{"key":"1551_CR83","doi-asserted-by":"publisher","first-page":"5405","DOI":"10.3390\/ijms20215405","volume":"20","author":"ZO Serebrovska","year":"2019","unstructured":"Serebrovska ZO, Serebrovska TV, Kholin VA, Tumanovska LV, Shysh AM, Pashevin DA, et al. Intermittent hypoxia-hyperoxia training improves cognitive function and decreases circulating biomarkers of Alzheimer\u2019s disease in patients with mild cognitive impairment: a pilot study. Int J Mol Sci. 2019;20:5405.","journal-title":"Int J Mol Sci"},{"key":"1551_CR84","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.neurobiolaging.2018.10.017","volume":"74","author":"Y Katsumata","year":"2019","unstructured":"Katsumata Y, Nelson PT, Estus S, Fardo DW. Initiative AsDN. Translating Alzheimer\u2019s disease\u2013associated polymorphisms into functional candidates: a survey of IGAP genes and SNPs. Neurobiol Aging. 2019;74:135\u201346.","journal-title":"Neurobiol Aging"},{"key":"1551_CR85","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.2119\/molmed.2012.00190","volume":"18","author":"A K\u00e4stner","year":"2012","unstructured":"K\u00e4stner A, Grube S, El-Kordi A, Stepniak B, Friedrichs H, Sargin D, et al. Common variants of the genes encoding erythropoietin and its receptor modulate cognitive performance in schizophrenia. Mol Med. 2012;18:1029\u201340.","journal-title":"Mol Med"},{"key":"1551_CR86","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.brainres.2012.06.055","volume":"1471","author":"GF Benderro","year":"2012","unstructured":"Benderro GF, Sun X, Kuang Y, LaManna JC. Decreased VEGF expression and microvascular density, but increased HIF-1 and 2\u03b1 accumulation and EPO expression in chronic moderate hyperoxia in the mouse brain. Brain Res. 2012;1471:46\u201355.","journal-title":"Brain Res"},{"key":"1551_CR87","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1113\/expphysiol.2006.033506","volume":"91","author":"RD Guzy","year":"2006","unstructured":"Guzy RD, Schumacker PT. Oxygen sensing by mitochondria at complex III: the paradox of increased reactive oxygen species during hypoxia. Exp Physiol. 2006;91:807\u201319.","journal-title":"Exp Physiol"},{"key":"1551_CR88","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1126\/science.1147949","volume":"318","author":"GL Semenza","year":"2007","unstructured":"Semenza GL. Life with oxygen. Science. 2007;318:62\u201364.","journal-title":"Science"},{"key":"1551_CR89","doi-asserted-by":"publisher","first-page":"958","DOI":"10.3390\/biom10060958","volume":"10","author":"A Hadanny","year":"2020","unstructured":"Hadanny A, Efrati S. The hyperoxic-hypoxic paradox. Biomolecules. 2020;10:958.","journal-title":"Biomolecules"},{"key":"1551_CR90","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1016\/j.cell.2019.03.045","volume":"177","author":"T Ast","year":"2019","unstructured":"Ast T, Meisel JD, Patra S, Wang H, Grange RM, Kim SH, et al. Hypoxia rescues frataxin loss by restoring iron sulfur cluster biogenesis. Cell. 2019;177:1507\u201321. e1516.","journal-title":"Cell"},{"key":"1551_CR91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s10020-021-00381-5","volume":"27","author":"M Begemann","year":"2021","unstructured":"Begemann M, Gross O, Wincewicz D, Hardeland R, Daguano Gastaldi V, Vieta E, et al. Addressing the \u2018hypoxia paradox\u2019 in severe COVID-19: literature review and report of four cases treated with erythropoietin analogues. Mol Med. 2021;27:1\u201311.","journal-title":"Mol Med"},{"key":"1551_CR92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s10020-020-00186-y","volume":"26","author":"H Ehrenreich","year":"2020","unstructured":"Ehrenreich H, Weissenborn K, Begemann M, Busch M, Vieta E, Miskowiak KW. Erythropoietin as candidate for supportive treatment of severe COVID-19. Mol Med. 2020;26:1\u20139.","journal-title":"Mol Med"},{"key":"1551_CR93","doi-asserted-by":"publisher","first-page":"7341","DOI":"10.1007\/s12035-015-9656-6","volume":"53","author":"M Zhang","year":"2016","unstructured":"Zhang M, Wu J, Huo L, Luo L, Song X, Fan F, et al. Environmental enrichment prevent the juvenile hypoxia-induced developmental loss of parvalbumin-immunoreactive cells in the prefrontal cortex and neurobehavioral alterations through inhibition of NADPH oxidase-2-derived oxidative stress. Mol Neurobiol. 2016;53:7341\u201350.","journal-title":"Mol Neurobiol"},{"key":"1551_CR94","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.stem.2010.11.028","volume":"8","author":"JE Le Belle","year":"2011","unstructured":"Le Belle JE, Orozco NM, Paucar AA, Saxe JP, Mottahedeh J, Pyle AD, et al. Proliferative neural stem cells have high endogenous ROS levels that regulate self-renewal and neurogenesis in a PI3K\/Akt-dependant manner. cell stem cell. 2011;8:59\u201371.","journal-title":"cell stem cell"},{"key":"1551_CR95","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/mp.2014.88","volume":"20","author":"A Monin","year":"2015","unstructured":"Monin A, Baumann P, Griffa A, Xin L, Mekle R, Fournier M, et al. Glutathione deficit impairs myelin maturation: relevance for white matter integrity in schizophrenia patients. Mol Psychiatry. 2015;20:827\u201338.","journal-title":"Mol Psychiatry"},{"key":"1551_CR96","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.abb.2012.08.002","volume":"534","author":"E Ostrakhovitch","year":"2013","unstructured":"Ostrakhovitch E, Semenikhin O. The role of redox environment in neurogenic development. Arch Biochem Biophys. 2013;534:44\u201354.","journal-title":"Arch Biochem Biophys"},{"key":"1551_CR97","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1002\/glia.20797","volume":"57","author":"D Sargin","year":"2009","unstructured":"Sargin D, Hassouna I, Sperling S, Sir\u00e9n AL, Ehrenreich H. Uncoupling of neurodegeneration and gliosis in a murine model of juvenile cortical lesion. Glia. 2009;57:693\u2013702.","journal-title":"Glia"},{"key":"1551_CR98","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1038\/jcbfm.2015.100","volume":"35","author":"M Mitkovski","year":"2015","unstructured":"Mitkovski M, Dahm L, Heinrich R, Monnheimer M, Gerhart S, Stegm\u00fcller J, et al. Erythropoietin dampens injury-induced microglial motility. J Cereb Blood Flow Metab. 2015;35:1233\u20136.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1551_CR99","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1002\/glia.23039","volume":"64","author":"G Poggi","year":"2016","unstructured":"Poggi G, Boretius S, M\u00f6bius W, Moschny N, Baudewig J, Ruhwedel T, et al. Cortical network dysfunction caused by a subtle defect of myelination. Glia. 2016;64:2025\u201340.","journal-title":"Glia"},{"key":"1551_CR100","first-page":"1","volume":"8","author":"K Khalid","year":"2015","unstructured":"Khalid K, Frei J, Aboouf MA, Koester-Hegmann C, Gassmann M, Fritschy J-M, et al. Erythropoietin stimulates GABAergic maturation in the mouse hippocampus. Eneuro. 2021;8:1\u201320.","journal-title":"Eneuro"},{"key":"1551_CR101","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1002\/ana.24545","volume":"79","author":"E Castillo\u2010Gomez","year":"2016","unstructured":"Castillo\u2010Gomez E, K\u00e4stner A, Steiner J, Schneider A, Hettling B, Poggi G, et al. The brain as immunoprecipitator of serum autoantibodies against N\u2010Methyl\u2010D\u2010aspartate receptor subunit NR1. Ann Neurol. 2016;79:144\u201351.","journal-title":"Ann Neurol"},{"key":"1551_CR102","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1038\/mp.2013.110","volume":"19","author":"C Hammer","year":"2014","unstructured":"Hammer C, Stepniak B, Schneider A, Papiol S, Tantra M, Begemann M, et al. Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood\u2013brain barrier integrity. Mol Psychiatry. 2014;19:1143\u20139.","journal-title":"Mol Psychiatry"},{"key":"1551_CR103","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.neuron.2014.12.032","volume":"85","author":"A Montagne","year":"2015","unstructured":"Montagne A, Barnes SR, Sweeney MD, Halliday MR, Sagare AP, Zhao Z, et al. Blood-brain barrier breakdown in the aging human hippocampus. Neuron. 2015;85:296\u2013302.","journal-title":"Neuron"},{"key":"1551_CR104","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.nlm.2018.02.023","volume":"150","author":"E Dere","year":"2018","unstructured":"Dere E, Ronnenberg A, Tampe B, Arinrad S, Schmidt M, Zeisberg E, et al. Cognitive, emotional and social phenotyping of mice in an observer-independent setting. Neurobiol Learn Mem. 2018;150:136\u201350.","journal-title":"Neurobiol Learn Mem"},{"key":"1551_CR105","doi-asserted-by":"publisher","first-page":"109548","DOI":"10.1016\/j.celrep.2021.109548","volume":"36","author":"LF Garcia-Agudo","year":"2021","unstructured":"Garcia-Agudo LF, Steixner-Kumar AA, Curto Y, Barnkothe N, Hassouna I, J\u00e4hne S, et al. Brain erythropoietin fine-tunes a counterbalance between neurodifferentiation and microglia in the adult hippocampus. Cell Rep. 2021;36:109548.","journal-title":"Cell Rep"},{"key":"1551_CR106","doi-asserted-by":"publisher","first-page":"14907","DOI":"10.1073\/pnas.0406491101","volume":"101","author":"M Brines","year":"2004","unstructured":"Brines M, Grasso G, Fiordaliso F, Sfacteria A, Ghezzi P, Fratelli M, et al. Erythropoietin mediates tissue protection through an erythropoietin and common \u03b2-subunit heteroreceptor. Proc Natl Acad Sci. 2004;101:14907\u201312.","journal-title":"Proc Natl Acad Sci"},{"key":"1551_CR107","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/cne.22020","volume":"514","author":"PE Sanchez","year":"2009","unstructured":"Sanchez PE, Navarro FP, Fares RP, Nadam J, Georges B, Moulin C, et al. Erythropoietin receptor expression is concordant with erythropoietin but not with common \u03b2 chain expression in the rat brain throughout the life span. J Comp Neurol. 2009;514:403\u201314.","journal-title":"J Comp Neurol"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-022-01551-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-022-01551-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-022-01551-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,12]],"date-time":"2022-11-12T22:03:20Z","timestamp":1668290600000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-022-01551-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,12]]},"references-count":107,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["1551"],"URL":"https:\/\/doi.org\/10.1038\/s41380-022-01551-5","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,12]]},"assertion":[{"value":"12 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}